BDBM616187 1-[4-Benzyloxy-3-(4-bromo-2- methyl-2H-pyrazol-3-yl)-phenyl]-3- (4-chloro-phenyl)-urea::US20230277505, Compound 61

SMILES Cn1ncc(Br)c1-c1cc(NC(=O)Nc2ccc(Cl)cc2)ccc1OCc1ccccc1

InChI Key InChIKey=KNHPQCFZWPOLFQ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 616187   

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM616187(US20230277505, Compound 61 | 1-[4-Benzyloxy-3-(4-b...)
Affinity DataIC50: 8.57nMAssay Description:For total binding, a total volume of 50 ul of appropriately diluted membranes (diluted in assay buffer containing 50 mM Tris HCl (pH 7.4), 10 mM MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent